Back to Peptide Encyclopedia
Immune SupportEmerging Research
VIP
Vasoactive Intestinal Peptide
28 amino acid neuropeptide with immunomodulatory and anti-inflammatory activity.
Research Only2 protocols
Research-only — no FDA/EMA approval
·Educational information. Not medical advice or a recommendation for use.Key Facts: VIP
Category
Immune Support
Evidence
Emerging Research
Availability
Research Only
Protocols
2
Amino Acids
28
Research Overview & Mechanisms
Acts through VPAC1/VPAC2 receptors, modulates cytokines and immune response.
Reported Research Benefits
Immunomodulation
Respiratory
Anti-inflammatory
Available Protocols
Frequently Asked Questions
FAQ
28 amino acid neuropeptide with immunomodulatory and anti-inflammatory activity.
Advanced Compound Intelligence
—
Human studies
—
Key studies
—
Interactions
Emerging Research
Evidence tier
Verified intelligence
Research summaryClinical Evidence
Emerging Research
View all studies on PubMedEarly-phase clinical trials or strong preclinical data with ongoing human studies.
Scientific Sources & Further Reading
Explore peer-reviewed research about VIP:
External links open in new tabs. Always verify information with qualified healthcare providers.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →